Follicular and Large B-Cell Lymphoma Cancer Survivor - Renee's Envita Review
A diagnosis of two types of Lymphomas, despite following a healthy lifestyle and eating nutritious food, had shocked Renee. She had started pursuing standard conventional treatments for her Follicular and Large B-Cell Lymphoma, but the severe side effects compelled her to opt for alternative treatment options. “I wanted to pursue something that would be gentler on me because I honestly didn't think I was going to survive six months of standard treatment,” said Renee Barclay, who traveled from Canada to seek treatment at Envita Medical Centers, a world-class integrative center for precision oncology, in Scottsdale, Arizona.
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
In-Depth Genomic Analysis for Detailed Understanding of the Cancer
Envita's proprietary genomic tests lay the foundation for custom developing a comprehensive treatment plan, which is aimed at precision-targeting the unique set of causes triggering cancer in each individual patient. Cancer is a disease of genetic mutations, not tissue types and organs, which is why attacking the core causes of the mutations helps in reducing the disease burden and effectively treating the disease.
Detailed Genomic Analysis to Address the Causes of Cancer
Renee was enthusiastic about pursuing a personalized and comprehensive treatment protocol, which would not only address her Lymphoma and its immediate symptoms but go deep into identifying and treating its root causative factors. Envita's detailed and proprietary genomic tests are designed to analyze many more parameters than standard oncology, to help in better understanding the unique set of factors responsible for causing cancer in each individual patient.
“They would look at how I got the cancer, what they would do to treat it and what they would do to prevent it from coming back,” said Renee, who was convinced with the unique personalized precision oncology treatment approach followed at Envita. She and her husband felt reassured in their detailed consultation with the physician, as he walked them through the comprehensive protocol and how it would be customized to precisely target Renee's cancer along with the causes of its growth and proliferation. “It gave us a real level of confidence that we are really a part of this process, and it mattered that we understand what's going on,” added Renee.
Proprietary Treatments to Maximize Cancer Kill
Certain proprietary treatments, like Envita's GTFC™ (Genetically Targeted Fractionated Chemotherapy), proved beneficial for Renee because it is based on detailed tests, which reveal the chemo drugs that may have a higher potential of cancer kill for each patient's individual cancer. GTFC™ maximizes the mechanisms of action against the cancerous cells by utilizing a greater number of chemo agents than standard untargeted maximum therapeutic dose chemotherapy. However, deploying the drugs in metronomic dosage makes it gentler on the patient and reduces the chances of side effects, typically associated with standard untargeted chemotherapy.
Personalized Immunotherapies for Lasting Outcome
Like Renee, every patient's treatment protocol at Envita includes some form of immunotherapies, irrespective of their stage and type of cancer, because we understand that the immune system is the first and last line of defense against any disease. Depending on the patient's unique cancer and its microenvironment, we utilize personalized immunotherapies of various levels, including custom-compounded adjuvants to the highest level of cellular immunotherapies, for potentiating patient responses.
Her Envita Connection
Renee was interested in seeking care at Envita after she was informed by a cousin about one of our former patients, who had also traveled from Canada to get treated at our facility. “He had gone through six months of standard treatment, which failed, and he then ended up doing some research and going to Envita and had a success story. And he was at that point at least three years into remission, then I thought that's what I would prefer to do,” added Renee. She feels that every patient should do their own research about the treatment options available for them and they should feel comfortable with their decision. “I would give the same advice that I was given, I don't think I would wait for a treatment to fail before I went to Envita,” added Renee, as she feels contented about her choice of treatment and wishes the same for other cancer patients.
Call Us Today
The expert team at Envita includes oncologists, interventional radiologists, researchers, and pharmacists, who collaborate to design a unique treatment plan, aimed at improving each patient's quality of life, increasing their longevity, and reducing toxicity. If you or any of your loved ones have questions regarding cancer, please feel free to call us at 866-830-4576.
